The latest news and updates about Positron
CROWN POINT, INDIANA—March 23, 2012 (BUSINESS WIRE)—Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology announces the approval of their Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the Company’s... Read More
LUBBOCK, TEXAS—February 21, 2012 (BUSINESS WIRE)—Positron Corporation (OTCBB:POSC), through its wholly owned subsidiary, Manhattan Isotope Technology, LLC (MIT), is proud to announce that on February 16, 2012, MIT, received its first shipment of Strontium-82(Sr-82) from the ARRONAX Cyclotron Facility in Nantes,... Read More
FISHERS, INDIANA—February 7, 2012 (BUSINESS WIRE)—Positron Corporation (OTCBB:POSC), through its wholly owned subsidiary, Manhattan Isotope Technology, LLC (MIT), is pleased to announce the execution of a Memorandum of Understanding with the Institute of Nuclear Research (INR) of Troitsk, Russia. MIT and INR will... Read More
FISHERS, INDIANA—January 27, 2012 (BUSINESS WIRE)—Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology, is pleased to announce that on January 23, 2012, its wholly owned subsidiary,... Read More
FISHERS, INDIANA—January 17, 2012 (BUSINESS WIRE)—Positron Corporation (OTCBB: POSC), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce the acquisition of Manhattan Isotope Technology, LLC (MIT). Positron has acquired all of the assets, business operations and... Read More
FISHERS, Ind. , Dec. 19, 2011 /PRNewswire/ – Positron Corporation (OTCBB: POSC.OB – News), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce that on December 16, 2011 , the Company received a nuclear pharmacy license from the Indiana Board of Pharmacy for the... Read More
